HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 194 filers reported holding HERON THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $74,000 | -43.9% | 12,997 | -10.1% | 0.06% | -41.0% |
| Q4 2021 | $132,000 | -21.4% | 14,456 | -8.2% | 0.10% | -29.1% |
| Q3 2021 | $168,000 | -32.5% | 15,755 | -1.7% | 0.15% | -32.4% |
| Q2 2021 | $249,000 | -14.7% | 16,030 | -11.0% | 0.22% | -17.4% |
| Q1 2021 | $292,000 | -24.2% | 18,005 | -0.9% | 0.26% | -30.4% |
| Q4 2020 | $385,000 | +42.6% | 18,170 | -0.3% | 0.38% | +33.2% |
| Q3 2020 | $270,000 | +0.4% | 18,220 | -0.4% | 0.29% | -2.4% |
| Q2 2020 | $269,000 | +24.5% | 18,295 | -0.4% | 0.29% | +15.4% |
| Q1 2020 | $216,000 | -51.1% | 18,370 | -2.3% | 0.25% | -44.2% |
| Q4 2019 | $442,000 | +20.1% | 18,795 | -5.5% | 0.46% | +19.1% |
| Q3 2019 | $368,000 | -0.5% | 19,885 | 0.0% | 0.38% | +0.3% |
| Q2 2019 | $370,000 | -23.9% | 19,885 | -0.1% | 0.38% | -24.6% |
| Q1 2019 | $486,000 | – | 19,905 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $1,900 | 100.00% |
| Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
| GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
| Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
| TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
| Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
| Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
| CM Management, LLC | 250,000 | $625 | 0.75% |
| Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |